Skip to content

Sagent Pharmaceuticals, Inc.

Delisted

CIK 1369786fmd_0RRKR0NE8W73FWGFV97QQPD97MManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2016, 26 periods

Latest annual · FY2015

Millions
Gross profit
88
Operating income
(45)
Net income
(22)
Free cash flow
(14)

Latest quarter · Q2 FY2016

Millions
Gross profit
17
Operating income
(0)
Net income
(1)
Free cash flow
(2)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2010 to FY2015
n/m

Sagent Pharmaceuticals, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Gross profit$87.7 million$86.2 million+1.8%10-K 2016-03-07 · proof
Operating income-$44.5 million$19 million-333.8%10-K 2016-03-07 · proof
Net income-$21.9 million$37 million-159.2%10-K 2016-03-07 · proof
Cash from operating activities-$7.5 million$22.2 million-133.9%10-K 2016-03-07 · proof
Free cash flow-$14.2 million$18 million-179.3%10-K 2016-03-07 · proof
Total assets$349.7 million$380 million-8%10-K 2016-03-07 · proof
Total liabilities$98.6 million$106.2 million-7.1%10-K 2016-03-07 · proof
Cash and cash equivalents$29 million$55.6 million-47.9%10-K 2016-03-07 · proof
Total debt$1.6 million$2.5 million-33.8%10-K 2016-03-07 · proof
What was Sagent Pharmaceuticals, Inc.'s gross profit in fiscal 2015?
Sagent Pharmaceuticals, Inc. reported gross profit of $87.7 million for fiscal 2015 (the year ended Dec 31, 2015), against $86.2 million the year before (+1.8%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What was Sagent Pharmaceuticals, Inc.'s operating income in fiscal 2015?
Sagent Pharmaceuticals, Inc. reported operating income of -$44.5 million for fiscal 2015 (the year ended Dec 31, 2015), against $19 million the year before (-333.8%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What was Sagent Pharmaceuticals, Inc.'s net income in fiscal 2015?
Sagent Pharmaceuticals, Inc. reported net income of -$21.9 million for fiscal 2015 (the year ended Dec 31, 2015), against $37 million the year before (-159.2%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What was Sagent Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2015?
Sagent Pharmaceuticals, Inc. reported cash from operating activities of -$7.5 million for fiscal 2015 (the year ended Dec 31, 2015), against $22.2 million the year before (-133.9%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What was Sagent Pharmaceuticals, Inc.'s free cash flow in fiscal 2015?
Sagent Pharmaceuticals, Inc. reported free cash flow of -$14.2 million for fiscal 2015 (the year ended Dec 31, 2015), against $18 million the year before (-179.3%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What are Sagent Pharmaceuticals, Inc.'s total assets?
As of Dec 31, 2015, Sagent Pharmaceuticals, Inc. reported total assets of $349.7 million, against $380 million a year earlier (-8%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What are Sagent Pharmaceuticals, Inc.'s total liabilities?
As of Dec 31, 2015, Sagent Pharmaceuticals, Inc. reported total liabilities of $98.6 million, against $106.2 million a year earlier (-7.1%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What are Sagent Pharmaceuticals, Inc.'s cash and cash equivalents?
As of Dec 31, 2015, Sagent Pharmaceuticals, Inc. reported cash and cash equivalents of $29 million, against $55.6 million a year earlier (-47.9%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC
What is Sagent Pharmaceuticals, Inc.'s total debt?
As of Dec 31, 2015, Sagent Pharmaceuticals, Inc. reported total debt of $1.6 million, against $2.5 million a year earlier (-33.8%). Source: the 10-K filed with the SEC on Mar 7, 2016. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1369786&period_type=annual&limit=5"

Information only, not investment advice.